Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing Il-12, in pet dogs with sporadic gliomas

Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing Il-12, in pet dogs with sporadic gliomas

Nidal B. Omar MD, R. Timothy Bentley BVSc, David K. Crossman PhD, Jeremy B. Foote DVM, PhD, Jennifer W. Koehler DVM, PhD, James M. Markert MD, MPH, Simon R. Platt BVM&S, Daniel R. Rissi DVM, MS, PhD, Andy Shores DVM, MS, PhD, Donald Sorjonen DVM, MS, Amy B. Yanke DVM, MS, G. Yancey Gillespie PhD, and Melissa R. Chambers DVM, MD

Neurosurg FocusVolume 50 • February 2021. DOI: 10.3171/2020.11.FOCUS20844.